PlaqueTec has recruited 100 patients into its BIOPATTERN trial, which [...]
Caristo Diagnostics’ CaRi-Heart technology has received US FDA De Novo [...]
PlaqueTec has recruited 100 patients into its BIOPATTERN trial, which [...]
Caristo Diagnostics’ CaRi-Heart technology has received US FDA De Novo [...]